The mouse CMAP assay prevalidated here is distinguishable
from the rat CMAP assay in that essential validation
characteristics were investigated according to ICH
guidelines. Linearity, accuracy, and precision results
showed that the BoNT/A doses within a linear range (i.e., 2–
40 U/mL) were quantifiable in the mouse CMAP assay
during three individual runs.